TP53 mutation in leukemia can occur in the context of somatic and germline mutations, the latter of which is associated with Li-Fraumeni syndrome leads to the development of specific solid tumors and is less likely to arise in diverse tissues [41]. The gene discussed is TP53; the disease is Li-Fraumeni syndrome.